UNIVERSAL BIOSENSORS INC. — Call Transcript 2016

Feb 16, 2016

Universal Biosensors, Inc. ARBN 121 559 993 1 Corporate Avenue Rowville Victoria 3178 Australia Telephone +61 3 9213 9000 Facsimile +61 3 9213 9099 Email info@universalbiosensors.com www.universalbiosensors.com

==> picture [90 x 62] intentionally omitted <==

Universal Biosensors – FY 2015 Results Conference Call

Melbourne, Australia ; 17 February 2016: Universal Biosensors (ASX:UBI) will be hosting an investor webcast to present the FY 2015 results on Friday, 19 February at 11am AEDT . The call will be hosted by Universal Biosensors Chief Executive Officer, Paul Wright.

Shareholders are invited to listen to a webcast of the full year results via the following link: http://webcasting.brrmedia.com/broadcast/56b823c9c23d9659538e181f

This webcast will be recorded and lodged on the ASX following the presentation.

The call can also be accessed by phone by dialling the numbers below and using conference ID 421317:

Australia toll free: 1800 558 698 Alternate Australia toll free: 1800 809 971 Hong Kong: 800 966 806 New Zealand: 0800 453 055 Singapore: 800 101 2785 United States: 1855 8811 339 United Kingdom: 0800 051 8245

-ENDS-

Enquiries: Paul Wright +61 3 9213 9000

About Universal Biosensors

For additional information in relation to Universal Biosensors, refer to http://www.universalbiosensors.com/announcements.html.

Universal Biosensors is a specialist medical diagnostics company, founded in 2001, that is focused on the development, manufacture and commercialisation of a range of in vitro diagnostic tests for point-of-care use. These tests capitalise on a technology platform which uses a novel electrochemical cell that can be adapted for multiple analytes and provide for enhanced measurements in whole blood.

Forward-Looking Statements

The statements contained in this release that are not purely historical are forward-looking statements within the meaning of the Exchange Act. Forward-looking statements in this release include statements regarding our expectations, beliefs, hopes, intentions or strategies regarding the proposed offering. All forward-looking statements

Universal Biosensors, Inc. ARBN 121 559 993

1 Corporate Avenue Rowville Victoria 3178 Australia

Telephone +61 3 9213 9000 Facsimile +61 3 9213 9099 Email info@universalbiosensors.com www.universalbiosensors.com

==> picture [90 x 62] intentionally omitted <==

included in this release are based upon information available to us as of the date hereof, and we assume no obligation to update any such forward-looking statement as a result of new information, future events or otherwise. Our actual results could differ materially from our current expectations. We cannot assure you when, if at all, the proposed offering will occur, and the terms of any such offering are subject to change. Factors that could cause or contribute to such differences include, but are not limited to, factors and risks disclosed from time to time in reports filed with the SEC.